Regeneron/Sanofi stops late-stage Libtayo study early after improvement in survival in NSCLC patients
05 August 2021 - 8:23PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2024 to May 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From May 2023 to May 2024